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ABSTRACT 
 
Twenty one base pair long small interfering RNAs (siRNAs) are widely in use in mammalian RNAi experi-
ments. The present study assesses the capability of 43 and 63bp dsRNAs with two 2nt long 3’-overhangs to 
induce RNAi in mammalian and Drosophila cells. Human Dicer was found to cleave these dsRNAs from 
their ends to generate two or three monomeric siRNA units, each 21-22bp in length. When, in 43bp dsRNA, 
there was present a highly-effective siRNA sequence in frame with respect to the Dicer digestion, considera-
bly high RNAi activity was noted to be induced in mouse embryonic stem E14TG2a, human HeLa, Chinese 
hamster CHO-K1 or Drosophila S2 cells. In contrast, RNAi depending on 63bp dsRNA, containing a highly 
effective siRNA sequence in frame with respect to Dicer digestion, varied considerably depending on cell 
lines used. While there was no appreciable RNAi in HeLa cells associated with relatively strong interferon 
response, a significant level of RNAi was noted in E14TG2a, CHO-K1 and S2 cells, in all of which inter-
feron response induction was but slight, if at all. It would thus follow that siRNA oligomers with sequence of 
a highly functional siRNA monomer unit in frame with respect to dicer digestion should serve as a good 
RNAi agent in Drosophila and certain mammalian cells. 
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INTRODUCTION 
 
RNAi  is  a  double-stranded  (ds)-RNA-dependent  process 
of gene silencing in eukaryotes (Dykxhoorn et al, 2003; 
Meister and Tuschl, 2004; Mello and Conte Jr, 2004). In 
Drosophila, long dsRNAs of a few to several hundred bp 
in length, are presently in use as effective RNAi agents 
(Ui-Tei et  al,  2000;  Boutros  et  al,  2004).  Long  dsRNA 
introduced or expressed within cells are digested by Dicer, 
an  RNase  III-family  member,  into  short  interfering 
dsRNAs  (siRNAs),  21-22bp  in  length  (Bernstein  et  al, 
2001;  Ketting  et  al,  2001),  which  are  incorporated  into 
RNA-induced silencing complexes (RISC). Active RISC 
is  considered  to  contain  only  the  antisense  strand  of 
siRNA  and  recognizes  target  mRNA  via  hydrogen-
bonding  and  eventually  cleaves  it  at  the  position  corre-
sponding to the middle of the siRNA antisense strand (El-
bashir et al, 2001a, 2001b, 2001c; Martinez et al, 2002). 
Ago protein performs a central role in mRNA processing 
(Hammond et al, 2001; Doi et al, 2003; Liu et al, 2004). 
 
RNAi  in  mammals  is  quite  similar,  if  not  identical,  in 
mechanism to RNAi in lower eukaryotes. However, most 
mammalian RNAi experiments are carried out using 21-
22bp siRNA instead of long dsRNA to avoid possible in-
terferon  response  (Elbashir  et  al,  2001b).  siRNA-
dependent RNAi in mammalian cells considerably varies 
depending on the sequence of the siRNA used (Holen et  
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al, 2002; Ui-Tei et al, 2004a). siRNA sequence preference 
rules have been previously reported (Ui-Tei et al, 2004a; 
Reynolds et al, 2004; Amarzguioui and Prydz, 2004).  
 
Short Dicer-substrate dsRNA has recently been shown to 
be much more functional than 21-22bp-long siRNA, and 
maximal inhibitory activity of short dsRNA to be present 
at a duplex of 27 bp (Kim et al, 2005). RNA duplexes 
longer than 27 bp were found to show progressive loss of 
functional RNAi activity and by 40-45bp, to be entirely 
inactive at 1nM – this too being correlated with poor in 
vitro  cleavage  of  the  duplexes  by  Dicer  (Kim  et  al, 
2005). 
 
These findings may not necessarily mean dsRNA longer 
than 40 bp to be incapable of inducing functional RNAi 
in mammalian cells. Indeed, RNAi in mammals was ini-
tially noted to occur on transfection of long dsRNA. Wi-
anny  et  al  (1999)  showed  the expression  of  GFP  gene 
introduced into mouse embryos to be effectively inacti-
vated by cognate long dsRNA. Ui-Tei et al (2000) found 
the  expression  of  exogenous  firefly  luciferase  gene  in 
CHO-K1 cells significantly abolished on transfection of 
long  cognate  dsRNA  or  expression  plasmid  encoding 
long hairpin RNA. 
 
As a first step in the clarification of the molecular basis 
for long dsRNA-depending RNAi in mammals, examina-
tion  was  made  as  to  whether  dsRNAs  equivalent  in 
length to siRNA dimers or trimers were capable of induc-
ing RNAi in mammalian and Drosophila cells and, if so, 
what conditions were required. Long dsRNA with two 2 
nt 3’-overhangs was shown effectively cleaved 21-22 bp 
from  its  ends  by  Dicer  and  should  the  sequence  of  a 
highly-effective  siRNA  such  as,  class  I  (Ui-Tei  et  al, 
2004a), be included in resultant siRNA monomer as the 
main Dicer digestion product, and if cells used for trans-
fection  were  tolerant  interferon  induction,  considerable 
RNAi induction may occur in mammals and Drosophila. 
 
MATERIALS AND METHODS 
 
dsRNA preparation 
dsRNAs  with  two  2  bp  long  3’-overhangs  were  enzy-
matically synthesized using the CUGA7 in vitro siRNA 
Synthesis  Kit  (Nippon  Genetech,  Japan)  (Figure  1A). 
Three deoxyoligonucleotides, oligo 1, oligo 2 and oligo 3 
were mixed in a 2:1:1 fashion and annealed. (N) 41 or 61 in 
oligo 2 and (N)  41  or 61 in oligo 3 are complementary in 
sequence to each other and serve as templates for dsRNA 
strand synthesis by CUGA7 polymerase. Annealing was 
carried out at 75°C for 5 min followed by 5 min incuba-
tion at room temperature. Annealed DNA solution thus 
generated (16 µl) was mixed with distilled water (14 µl), 
5 x transcription buffer (8 µl), NTP solution (12 µl) and 
CUGA7 solution (2 µl). dsRNA synthesis was carried out 
by incubating the reaction mixture at 37°C for 2 hr. Re-
sultant dsRNA contains an additional guanine residue at 
each 5’end. These guanine residues and template DNA 
were  simultaneously  eliminated  by  incubating  at  37°C 
for 2 hr in the presence of DNase I, RNase T1 and BSA. 
See the manufacturer protocol for other details. dsRNA 
was  purified  by  phenol/chloroform/isoamyl alcohol  ex-
traction followed by ethanol precipitation. siRNAs were 
chemically  synthesized  by  Proligo  and  purified  as  de-
scribed previously (Ui-Tei et al, 2004a). 
 
In vitro Dicer cleavage  
dsRNA  was  incubated  with  recombinant  human  Dicer 
(Stratagene)  in  the  presence  of  RNase  inhibitor  (0.4 
units/µl; Promega), 20 mM Tris-HCl (pH 8.0), 150 mM 
NaCl  and  2.5  mM  MgCl2  at  37˚C.  Digestion  products 
were  size-fractionated using  15% (w/v)  non-denaturing 
polyacrylamide TBE gel, stained with SyberGreen II and 
analyzed by LAS-3000 (FUJIFILM). Digestion products 
were also size-fractionated using 15% (w/v) denaturing 
polyacrylamide TBE gel with 7M Urea and analyzed by 
FLA2000 imageanalyzer (FUJIFILM). 
 
Cell culture 
S2, CHO-K1, E14TG2a and HeLa cells were cultured as 
described  previously  (Ui-Tei  et  al,  2004a).  T98G  cells 
were cultured in Dulbecco’s Modified Eagle’s Medium 
(DMEM; Gibco BRL) at 37˚C. 
 
RNAi assay in cultured cells 
One milliliter of S2 (1 x 10
6 cells/ml), CHO-K1 (3 x 10
5 
cells/ml),  E14TG2a  (2  x  10
5  cells/ml),  HeLa  (1  x  10
5 
cells/ml) or T98G (2 x 10
5 cells/ml) cell suspension was 
inoculated into a 1.5-cm well 24 hr prior to transfection.  
For luc RNAi assay, cells were transfected with pGL3-
Control DNA (1 µg, Promega) encoding firefly luciferase 
and pRL-SV40 DNA (0.1 µg, Promega) encoding Renilla 
luciferase,  with  or  without  dsRNA.  The  calcium  phos-
phate precipitation method was used for transfection for 
S2,  while  Lipofectamine  2000  (Invitrogen),  CHO-K1, 
E14TG2a, HeLa and T98G cells. Cells were harvested 24 
hr after transfection and luciferase activity was measured 
using  the  dual-luciferase  assay,  in  which  firefly  and 
Renilla luciferases served as target and reference, respec-
tively. For EGFP or DsRed RNAi assay, cells were trans-
fected with a 1:1 mixture of pCAGGS-EGFP DNA (Ui-
Tei et al, 2004a; 0.2 µg) and pCAGGS-DsRed DNA (Ui-
Tei et al, 2004a; 0.2 µg), with or without dsRNA, and the 
cells were observed under fluorescent microscope (Zeiss) 
48 hr after transfection. For EGFP RNAi assay, DsRed 
served as an internal control and vice versa. For EGFP 
and DsRed double knockdown, EGFP and DsRed activ-
ity in cells untreated with dsRNA was used as an external 
control. Co-transfection efficiency of target and reference 
DNA  was  nearly  100%  (see  Figure  3A1,  B1,  C1)  and 
more than 90%  of target signals were eliminated upon 
active dsRNA cotransfection (see, e.g., Figure 3A3). 
 
Detection of interferon response  
Interferon  response  in  human  (HeLa  and  T98G)  and 
mouse  (E14TG2a)  cells  was  examined  using  RT-PCR. 
As  interferon-response  markers,  STAT1b,  OAS1-3  and 
IFNMP2 were used. GAPDH was used as a control. Cells 
were transfected with pCAGIpuro-EGFP DNA (0.2 µg) 
encoding the EGFP and puromycin resistant genes irre-
spective  of  dsRNA  treatment.    Transfected  cells  were 
selected by a 24 hr puromycin (2 µg/ml) treatment initi-
ated  24  hr  after  transfection.    The  total  RNA  was  ex-
tracted  and  purified  with  TRIZOL  (Invitrogen).  RNA 
used was 0.5 µg. Other details are described in the manu- 
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facture’s protocol. A 1 µl aliquot of the RT reaction mix-
ture was PCR amplified using AmpliTaqGOLD (Invitro-
gen). After they preheated at 94°C for 10 min, the sample 
was subjected to PCR (95°C (15sec)-55°C (30sec)-72°C 
(60sec), 18-30 cycles). The following PCR primers were 
used: 
 
hGAPDH 
5’CAAGGCTGAGAACGGGAAGCT, and 
5’GACACGGAAGGCCATGCCAGT 
hSTAT1b 
5’CAGAGCACAGTGATGTTAGAC, and 
5’GTGATAGGGTCATGTTCGTAG 
hOAS1 
5’GGAACATGAGGTGGCTGTGCT, and 
5’TTGGTACCAGTGCTTGACTAG 
hOAS2 
5’TCCTAGAGCAGATTGACAGTG, and 
5’CCAGGCATAGATGGTGAGCAG 
hOAS3 
5’GCAACAGCATCAGCAGCTCTG, and 
5’TGACCTCGAACTGCCGCTCCT 
hIFNMP2 
5’GGAACATGAGGTGGCTGTGCT, and 
5’AGCCGAATACCAGTAACAGGA 
mGAPDH 
5’GCCTCGTCCCGTAGACAAAA, and 
5’ACTGTGGTCATGAGCCCTTC 
mSTAT1b 
5’CAGAACACTGTGATGTTAGAT, and 
5’GTAATAGGGTCGGGCTCATAG 
mOAS2 
5’TCCTAAAGCAGATCAAGGAAG, and 
5’CCAGGCATACACGGTGAGCAG 
mOAS3 
5’GGGTCAGCAAGGGCGGCTCT, and 
5’GGAGCATCACCTGCCGCCTCT. 
 
RESULTS 
 
Effective conversion of siRNA dimers and trimers to 
monomer units through Dicer cleavage from RNA ends 
with 2 nt-long 3’overhangs 
RNA duplexes with two 2 nt long 3’overhangs and equiva-
lent  in  length  to  siRNA  dimers  (D1,D2)  and  trimers 
(T1,T2)  were  synthesized following  the CUGA7 system 
(Figure 1A). Resultant dsRNAs were terminally digested 
by Dicer by 4 hr incubation at 37°C to generate 21-22 bp-
long  dsRNA  as  the  main  reaction  products  (Figure1B). 
Quantitative Dicer digestion analysis was also carried out 
using  T1  as a  substrate  (Figure1C).  63  bp  signals  were 
almost completely converted to 21-22 bp signals without 
generating any significant amount of possible intermedi-
ates. These findings may indicate Dicer to be considerably 
high  in processivity, and 43 and  63 bp  dsRNA to have 
been cleaved in two and three siRNA monomer units, re-
spectively.  To further confirm this, a 30 bp long dsRNA 
with  two  2nt-long  3’overhangs  was  chemically  synthe-
sized, end-labeled with 
32P and subjected to Dicer diges-
tion (Figure 1D). As anticipated, Dicer digestion generated 
two 
32P-labeled products, 21-22 bp and 8-9 bp in length. 
Dicer thus appears capable of functioning as exonuclease 
to release successively 21-22bp siRNAs from the two ends 
of long dsRNA with two 2 nt long 3’overhangs. As sche-
matically shown in Figure 1E, any given siRNA monomer 
sequence in the Dicer substrate dsRNA is considered to be 
in either in-frame or out-of-frame configurations with re-
spect to Dicer digestion; the frame-unit size is 21-22 bp. 
 
Induction  of  functional  RNAi  by  siRNA  dimer  or 
trimer transfection 
Only a fraction of siRNA (highly effective siRNA or ac-
tive  siRNA)  has  been  shown  capable  of  inducing  high 
RNAi activity in transfected mammalian cells (Ui-Tei et 
al, 2004a; Naito et al, 2004). Thus, RNAi due to dimer- or 
trimer-sized  dsRNAs  may  be  considered  effectively  in-
duced in mammalian cells only when an active siRNA is 
produced in cells from transfected dimer- or trimer-sized 
cognate  dsRNA  as  a  major  Dicer-digestion  product.  In 
Drosophila,  most  cognate  siRNAs  effectively  induce 
RNAi  (Ui-Tei  et  al,  2004a)  and  accordingly,  nearly  all 
long cognate dsRNA should be active. But on using for 
RNAi induction a hetero-oligomer  of siRNAs,  in which 
only one monomer unit is homologous in sequence to tar-
get mRNA, a similar phase problem of effective siRNA 
will have to be encountered even in Drosophila RNAi. 
 
For the solution, HeLa cells (human), CHO-K1 (Chinese 
hamster)  and  E14TG2a  (mouse  embryonic  stem  (ES)) 
cells along with Drosophila S2 cells were transfected with 
D1 and D2, each containing M1, a highly functional class I 
siRNA sequence for luc inactivation (see the lower margin 
of Figure 2A, 2B). In D1, the M1 sequence is situated in a 
terminal half and thus should be released intact from D1 
through in vivo Dicer function (see the lower margin of 
Figure 2B). In all cell lines examined, D1 induced signifi-
cant  levels  of  RNAi,  although  RNAi  in  HeLa  cells  ap-
peared less effective (Figure 2B). In contrast, in D2, the 
M1 sequence is situated in a region out of frame with re-
spect to Dicer digestion (see the lower margin of Figure 
2B) and thus, is broken in the central region by Dicer with 
no appreciable RNAi activity production (Figure 2B). 
 
To determine whether siRNA-dimer-dependent RNAi oc-
curs  in individual  cells and  whether  two  active  siRNAs 
presumed to be released from an identical dsRNA 43bp 
long are simultaneously functional, 4 types of siRNA het-
erodimers  (D3-D6) were constructed,  each consisting  of 
two siRNA monomer sequences homologous to those of 
DsRed  and  EGFP  genes  (see  the  lower  margins  of 
Fig.3A,B),  using  highly  functional  and  non-functional 
siRNA sequences. The heterodimers were transfected into 
CHO-K1 and HeLa cells (Figure 3A2-6, B2). The specific-
ity of siRNA-dimer-dependent RNAi appeared to depend 
on the capability of siRNA monomer units (Figure 3A1-4, 
B) and 5’→3’ direction of antisense strand of each com-
ponent siRNA was not essential for RNAi induction (e.g., 
compare  Figures  3A5  and  A6).  When  two  monomeric 
siRNA  units  were  highly  active,  two  target  genes  were 
simultaneously knocked down (Figure 3A5, 6). 
 
T1 is comprised of three active siRNA sequences targeting 
EGFP, luc and DsRed, all in frame with respect to Dicer 
digestion (see the lower panel of Figure 2C).  But in T2, 
EGFP and DsRed siRNA monomer units are in an out-of-
frame  position and the luc siRNA sequence is divided into   
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Figure 1. CUGA7-polymerase-dependent synthesis (A) and Dicer digestion (B-D) of 43, 63 and 30 bp dsRNAs with two 2 nt 
3’overhangs. (A) dsRNA synthesis procedure; N, X, Y=A,T,G or C. W, Z = A,T or G. Underline, complementary nucleotide. L-
shaped arrows, Templates for dsRNA strands. (B) Nucleotide sequences of 43bp (D1/D2) and 63bp (T1/T2) dsRNAs are shown in 
the lower margins of Fig.2B,C. dsRNA (200 ng/µl) was digested with Dicer (0.05 units/ml) for 4 hr at 37˚C. (C) Time course of 
Dicer digestion of T1. (D) Dicer (0.005 units/ml) digestion of 30bp-long dsRNA (0.05 pmol/µl) with two 2bp-long 3’overhangs. Red 
and blue asterisks, respectively, show 
32P-labeled and non-labeled ends. Presumed Dicer cleavage is shown in the lower margin. (E) 
Dicer cleavage model. Active monomer siRNA is presumed to be generated only when its sequence in long dsRNA is in frame with 
respect to Dicer digestion. 
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Figure 2.  43/63bp-dsRNA-dependent RNAi. Relative luc activity in S2, CHO-K1, E14TG2a and HeLa cells was examined. Dotted 
red lines in B and C, respectively, show dose-response curves for single transfection of M1 and M2 active siRNAs.  (A) Control. 
siRNA-dependent RNAi. M1 and M2, active siRNAs. (B) 43bp-dsRNA-dependent RNAi. As 43bp dsRNA, D1 and D2 were used. 
The M1 sequence in D1 is in frame with respect to dicer digestion, while that in D2 is out of frame. D1 transfection induced consid-
erable RNAi activity in all cell lines used, whereas D2 transfection induced no or little RNAi. (C) 63bp-dsRNA-dependent RNAi. 
The M2 sequence in T1 is in frame with respect to dicer digestion if 21bp is used as a frame-unit size. However, no 21-22bp active 
siRNA is produced should the frame-unit size be only 22bp (see green and red hooked lines). The M2 sequence in T2 is out of frame 
with respect to dicer digestion. T2 transfection produced no or little RNAi activity in all cell lines examined, whereas T1 transfection 
induced considerable levels of RNAi activity in S2 and E14TG2a cells but not in CHO-K1 and HeLa. 
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Figure 3. siRNA-dimer/trimer-dependent RNAi. siRNA dimers and trimers, whose sequences are shown in the lower margin of each 
panel triplet, were constructed using nucleotide sequences of active or inactive siRNAs for EGFP, DsRed and luc gene knock-down. 
The expression and nucleotide sequences of EGFP were colored in green, while those of DsRed were colored in red. The nucleotide 
sequences of 3’overhangs, which may not be essential for gene knock-down, are not necessarily identical to those of original 
siRNAs. These are colored in black. Gene knock-down effects were observed 48 hours after transfection.  Left-most panels, phase 
contrast pictures. Arrows, 5’→ 3’ direction of the antisense strand of monomer units. A1-6, CHO-K1 cells. A1, Mock. A2, D2 trans-
fection. D2 is unrelated in sequence to targets. A3, D3 transfection. D3 = inactive EGFP siRNA + active DsRed siRNA. Only DsRed 
signals were reduced. A4, D4 transfection. D4 = active EGFP siRNA + inactive DsRed siRNA. Only EGFP signals were reduced.  
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A5, D5 transfection. D5 = active EGFP siRNA + active DsRed siRNA. Both DsRed and EGFP signals were reduced. A6, D6 trans-
fection.  D6 = active EGFP siRNA + active DsRed siRNA. Both DsRed and EGFP signals were reduced. B1,2, HeLa cells. B1, 
Mock. B2, D3 transfection. Only DsRed signals were reduced. C1-3, E14TG2a cells. C4-6, CHO-K1cells. C1,4, Mock. C2,5, T1 
transfection. T1 = active EGFP siRNA + active luc siRNA + active DsRed siRNA. Note EGFP and DsRed signals were significantly 
reduced in both E14TG2a and CHO-K1. C3,6, abortive gene-silencing in cells transfected with T2, having no in-frame siRNA se-
quences for EGFP and DsRed knock-down. 
 
 
 
two parts (see the lower panel of Figure 2C). On using 
E14TG2a and S2 cells for transfection, T1 but not T2 in-
duced  considerably  high  RNAi  activity  to  eliminate  luc 
(Figure 2C), EGFP and DsRed gene activity (Figure 3, C1-
3). However, no appreciable RNAi activity could be de-
tected in HeLa (Figure 2C). In  CHO-K1 cells, although 
only a low level of luc RNAi was evident (Figure 2C), 
EGFP and DsRed expression was significantly abolished 
through T1 transfection (Figure 3C, 4-6), possibly suggest-
ing T1 to cleave mainly 22 bp from ends through CHO-K1 
Dicer (see green and red hooked lines in the lower margin 
of Figure 2C). 
 
The above findings suggest that 43-63 bp long dsRNAs 
may be capable of considerable RNAi induction in certain 
mammalian  and  Drosophila  cells,  should  a  highly-
effective siRNA sequences be present in frame with re-
spect to Dicer digestion. 
 
Poor induction of interferon response in ES cells 
dsRNA  transfection-dependent  change  in  interferon  re-
sponse in HeLa, T98G (human) and E14TG2a cells was 
examined  by  monitoring  the  expression  of  a  number  of 
interferon  response  marker  genes  such  as,  2’,5’-
oligoadenylate synthetase (OAS)1-3, signal transducer and 
activator  of  transcription  (STAT)1b  and  interferon-
inducible transmembrane protein (IFNMP)2 (Sledz et al, 
2003).  dsRNA  concentration  for  transfection  was  0.6 
µg/ml, which is equivalent to 50 nM in 21bp siRNA.  In-
terferon response induction, however, varied considerably 
from cell line to cell line when transfected with D4 or T2. 
As previously reported, interferon response was greatest in 
T98G cells where RNAi may not be effectively induced 
(Sledz et al, 2003).  HeLa cells transfected with D4 or T2 
exhibited considerable interferon response but only slight, 
if any, increase in interferon response could be detected in 
E14TG2a cells transfected with D4 or T2 (Figure 4). In all 
cases, interferon response induced by monomer was very 
low, if any, and that induced by dimer was virtually the 
same as that by trimer.   
 
DISCUSSION 
 
The present findings indicate siRNA dimer and trimer ca-
pable  of  efficiently  inducing  RNAi,  provided  these  oli-
gomers possess two 2nt-long 3’overhangs and contain an 
active monomer unit in frame with respect to Dicer diges-
tion and suitable transfection cells are used. 
 
Previous  work  demonstrated  RNA  duplexes  40-45bp  in 
length not only to be poor substrates for Dicer processing 
but  also  to  be  incapable  of  inducing  efficient  RNAi  in 
HEK293 cells (Kim et al, 2005). The present work demon-
strated that 43 mers are good substrates for Dicer process-
ing (Figure 1B) and inducers of efficient RNAi (Figures 2 
and 3). These differences may be due to the fact that the 
duplexes  employed  in  the  Kim  et  al’s  work  were  blunt 
while those used in the present work possessed ends with 2 
nt 3’-overhangs. Dicer is presumed to cleave off siRNAs 
from the termini of dsRNA substrates (Zhang et al, 2002), 
and to function through intramolecular dimerization of its 
two  RNaseIII  domains,  assisted  by  the  flanking  RNA 
binding  domains, PAZ and  dsRBD (Zhang et al, 2004). 
Vermeulen et al (2005) have recently shown that 61mer 
dsRNA containing blunt and those with 3’overhang ends 
are processed in distinctly different manners and pointed 
out the importance of interactions between dsRNA ends 
and the PAZ domain of Dicer for specificity and efficiency 
in dicing. Figure 1D shows that RNA duplexes with 2-nt 
3’-overhangs  are  specifically  cleaved  at  points  21-22bp 
from the ends. During the preparation of this manuscript, 
Rose et al (2005) reported that blunt 27mer duplexes re-
sulted  in  a  wide  variety  of  dicing  patterns  while  major 
Dicer  cleavage  sites  of 27  mers  with  2 nt  3’-overhangs 
were located 21-22bp from the overhang. Thus, the pres-
ence  of  2nt-long  3’overhangs  is  critically  important  for 
sequential in-frame dicing of dsRNA. 
 
In HeLa cells, interferon response significantly increased 
with transfection of siRNA dimer or trimer but not mono-
mer (Figure 4). In contrast, in E14TG2a cells, dimer/trimer-
dependent induction of interferon response was but slight, 
if at all (Figure 4). TLR7 or 8, Toll-like receptors, have 
recently been shown to be involved in the recognition of 
the immunostimulatory siRNA motifs, which is essential 
for  induction  of  the  interferon  pathway  (Hornung  et  al, 
2005; Agrawal et al, 2005; Sledz et al, 2003; Judge et al, 
2005; Sioud, 2005). Thus, difference in induction of inter-
feron responses by different cell types and dsRNA lengths 
may be a reflection  of interactions between TLR7/8 and 
immunostimulatory motifs of siRNA. Consistent with this 
M1 monomer lacking GU induced the lowest level of inter-
feron response in all cells examined, while interferon re-
sponse was increased in both HeLa and T98G cells with 
increasing the content of GU motifs (Figure 4; see also, 
Sioud, 2005). M2, D4 and T2, respectively, contain 3, 5, 
and 8 GU residues. However, in all four dsRNAs exam-
ined,  neither  5’UGUGU  (Judge  et  al,  2005)  nor 
5’GUCCUUCAA (Hornung et al, 2005) was found. 
 
Induction in interferon response and RNAi activity may 
not always be correlated to each other. Indeed, our results 
indicated  that,  in  HeLa  cells  transfected  with  a  siRNA 
dimer not only have considerable RNAi activity but also 
interferon response is virtually the same as that for a trimer 
dsRNA-transfected HeLa cells (Figures 2B, 3B and 4A). 
In CHO-K1 cells, which appear tolerant to long dsRNA 
transfection (Ui-Tei et al, 2000,  2004b),  T1 transfection 
gave rise to only a marginal level of RNAi for luc (Figure 
2C),  but  a  considerable  level  of  RNAi  for  EGFP   and  
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Figure 4. siRNA-oligomer-dependent interferon response. Change in expression of interferon response markers (OAS1-3, STAT1b 
and IFNMP2) in E14TG2a, HeLa and T98G cells were examined using RT-PCR. GAPDH, control.  Lane 1; plasmid DNA transfec-
tion. Lanes 2-5, respectively, corresponds to transfection of M1, M2, D4 and T2.  Numerals in parentheses, Amplification cycles. In 
all cases except for T98G transfected with M2, monomeric siRNAs (M1 and M2) induced only marginal, if any, interferon response. 
The highest level of interferon response was observed in T98G cells transfected with D4 and T2, while that in HeLa cells was con-
siderable and that in E14TG2a cells was very low, if any. 
 
 
 
DsRed (Figure 3C). In T1, EGFP and DsRed siRNA se-
quences are terminally situated, but luc is in a central third. 
We consider that this position-dependent difference in T1-
induced RNAi activity might be partly due to 1-2 bp am-
biguity in framing by Dicer, which is capable of generat-
ing two-three distinct siRNA monomers in length (see the 
lower margin of Figure 2C). 
 
One  advantage  of  having  a  dimer  or  trimer  dsRNA  for 
gene silencing is that multiple siRNAs targeting one gene 
or multiple genes could be produced in all cells transfected 
with a single dsRNA. The simplest way to eliminate the 
off-target effect is considered to simultaneously introduce 
multiple siRNAs for a single target gene into cells (Jack-
son and Linsley, 2004). Simultaneous knock -down of the 
target gene and one of interferon response inducing genes 
would  be  required  for  future  therapeutic  application  of 
RNAi. In Drosophila DNA encoding dsRNA, more than 
500bp in length, is still capable of inducing highly func-
tional RNAi to render UAS-constructs capable of generat-
ing double or triple mutant clones essential for conducting 
mosaic analysis or sophisticated analysis of development 
of various tissues. 
 
CONCLUSIONS 
 
As with 21bp siRNA, siRNA dimer or trimer, each con-
taining a highly functional siRNA sequence as a monomer 
unit, was found capable of efficiently inducing RNAi in 
transfected cells. 
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